After A -0.93% Drop In Share Price, Is Revance Therapeutics Inc (NASDAQ:RVNC) A Better Trade Than Others?
In recent trading session, Revance Therapeutics Inc (NASDAQ:RVNC) saw 0.68 million shares changing hands at last check today with its beta currently measuring 0.84. Company’s